These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 6379149)

  • 1. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
    Harden TK; Meeker RB; Martin MW
    J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide.
    Ehlert FJ; Roeske WR; Yamamura HI
    J Supramol Struct; 1980; 14(2):149-62. PubMed ID: 7230804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP; Posner P
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
    Waelbroeck M; Robberecht P; Chatelain P; Christophe J
    Mol Pharmacol; 1982 May; 21(3):581-8. PubMed ID: 7110116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the properties of muscarinic cholinergic receptors in the developing chick myocardium.
    Hosey MM; McMahon KK; Danckers AM; O'Callahan CM; Wong J; Green RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):795-801. PubMed ID: 3973828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates.
    Galper JB; Dziekan LC; O'Hara DS; Smith TW
    J Biol Chem; 1982 Sep; 257(17):10344-56. PubMed ID: 7107608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
    J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MgCl2-sensitive and Gpp(NH)p-sensitive antagonist binding states of rat heart muscarinic receptors: preferential detection at ambient temperature assay and location in two subcellular fractions.
    Sulakhe PV; Jagadeesh G; Phan NT; Rao TS; Veeranjaneyulu A
    Mol Cell Biochem; 1990 May; 94(2):133-46. PubMed ID: 2374547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of paired M2 muscarinic receptors.
    Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations.
    McMahon KK; Hosey MM
    Mol Pharmacol; 1985 Nov; 28(5):400-9. PubMed ID: 4058421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptors in porcine caudate nucleus. I. Enhancement by nickel and other cations of [3H]cis-methyldioxolane binding to guanyl nucleotide-sensitive sites.
    Nukada T; Haga T; Ichiyama A
    Mol Pharmacol; 1983 Nov; 24(3):366-73. PubMed ID: 6633503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity binding of [3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides.
    Gurwitz D; Kloog Y; Sokolovsky M
    Mol Pharmacol; 1985 Sep; 28(3):297-305. PubMed ID: 4033630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.